Search results
Pfizer Inc. (NYSE:PFE) Shares Sold by Trust Co. of Vermont
ETF DAILY NEWS· 7 days agoTrust Co. of Vermont lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing ...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 5 days agoPfizer currently dominates the market for pneumococcal vaccines, which protect against bacterial...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 6 days agoThe state of Kansas has filed a lawsuit against Pfizer alleging the company misled the public about...
Pfizer 'can't rule out' layoffs in North Carolina after gene therapy flub - Triangle Business...
The Business Journals· 5 days agoLayoffs could by on the way at Pfizer's massive facility in Sanford after the company's gene therapy...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 2 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 4 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 6 days agoWhen it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent...
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
Morningstar· 6 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday ...
Kansas AG Kris Kobach accuses Pfizer of misleading vaccine marketing in lawsuit
Kansas Reflector via Yahoo News· 6 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 5 days agoPfizer Currently Dominates Market FDA approval of Merck’s new pneumococcal vaccine, Capvaxive, tees...